Astellas Pharma Inc.  _ Annual Report 2014 138 29. provisions The movement of provisions for the year ended 31 March 2013 is as follows: The movement of provisions for the year ended 31 March 2014 is as follows: Details of provisions are as follows: 2. Asset retirement obligations 1. Trade-related provisions The Group recognises provisions for expenditures expected to  be incurred after the end of the period related to sales rebates,  discounts, Medicare and Medicaid of the United States, and  other price adjustments to customers, based on the conditions  of contracts and past experience. The outflow of economic benefits is expected within one  year from the end of the reporting period. The Group recognises asset retirement obligations based on  past performance in order to provide for the restoration of  rented offices. The outflow of economic benefits is expected after one year  from the end of the reporting period. (Millions of yen) Trade-related  provisions Asset retirement  obligations Other Total Balance at 1 April 2013 ¥ 43,904 ¥ 855 ¥ 5,221 ¥ 49,980 Increase during the year 59,571 1,249 4,061 64,880 Decrease due to intended use (46,472) (21) (2,365) (48,858) Reversal during the year — (1) (341) (341) Other 4,401 31 578 5,010 Balance at 31 March 2014 61,404 2,113 7,154 70,671 Non-current — 2,110 2,154 4,264 Current 61,404 3 5,000 66,407 Total provisions ¥ 61,404 ¥2,113 ¥ 7,154 ¥ 70,671 (Millions of yen) Trade-related  provisions Asset retirement  obligations Other Total Balance at 1 April 2012 ¥ 30,191 ¥1,019 ¥ 2,957 ¥ 34,167 Increase during the year 38,412 98 3,688 42,198 Decrease due to intended use (30,222) (262) (1,714) (32,198) Reversal during the year — — (299) (299) Other 5,523 1 589 6,113 Balance at 31 March 2013 43,904 855 5,221 49,980 Non-current — 837 1,054 1,891 Current 43,904 18 4,167 48,089 Total provisions ¥ 43,904 ¥ 855 ¥ 5,221 ¥ 49,980